AbbVie | ABBV - Ebitda





Ebitda Veränderung Datum
AbbVie USD 6.91B 3.22B 2026-06
Abbott USD 2.43B 844M 2026-03
ALKERMES USD 120.06M 19.15M 2026-09
Amgen USD 5.8B 1.25B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eisai JPY 34.15B 34.48B 2026-06
Eli Lilly USD 9.46B 3.54B 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
J&J USD 8.99B 721M 2026-06
Medtronic USD 2.63B 174M 2026-06
Merck USD 1.42B 2.97B 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 156.6M 83M 2026-09
Pfizer USD 6.36B 350M 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
UCB EUR 1.6B 570M 2025-12
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
United Therapeutics USD 334.2M 20.8M 2026-09
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09
Zoetis USD 1.07B 21M 2026-09